Doporučení a guidelines
Konsenzuální doporučení skupiny
Definice resekčních okrajů, reportování krčních disekcí a vyšetřování HPV/p16 (PDF)Mezinárodní doporučení a guidelines
Obecné:
Machiels JP, René Leemans C, Golusinski W, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(11):1462-1475. doi: 10.1016/j.annonc.2020.07.011.
Maghami E, Ismaila N, Alvarez A, et al. Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. J Clin Oncol. 2020; 38(22):2570-2596. doi: 10.1200/JCO.20.00275.
Koyfman SA, Ismaila N, Crook D, et al. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019; 37(20):1753-1774. doi: 10.1200/JCO.18.01921.
Forastiere AA, Ismaila N, Lewin JS, et al. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018; 36(11):1143-1169. doi: 10.1200/JCO.2017.75.7385.
Patologie:
Fakhry C, Lacchetti C, Rooper LM, et al. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. J Clin Oncol. 2018; 36(31):3152-3161. doi: 10.1200/JCO.18.00684.
Chirurgie:
Odell E, Eckel HE, Simo R et al. European Laryngological Society position paper on laryngeal dysplasia Part I: aetiology and pathological classification. Eur Arch Otorhinolaryngol. 2020 Oct 13. doi: 10.1007/s00405-020-06403-y. Online ahead of print.
Eckel HE, Simo R, Quer M, et al. European Laryngological Society position paper on laryngeal dysplasia Part II: diagnosis, treatment, and follow-up. Eur Arch Otorhinolaryngol. 2020 Oct 14. doi: 10.1007/s00405-020-06406-9. Online ahead of print.PMID: 33058010 Review.
Remacle M., Eckel HE, Antonelli A, et al. Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol 2000, 257(4): 227-231.
Remacle M., Van Haverbeke C, Eckel HE, et al. Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol 2007;264(5): 499-504.
Remacle, M., A. Hantzakos, H. Eckel et al. Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol 2009; 266(7): 993-998.
Succo G, Peretti G, Piazza C, et al Open partial horizontal laryngectomies: a proposal for classification by the Working Committee on nomenclature of the European Laryngological Society. Eur Arch Otorhinolaryngol. 2014 Sep;271(9):2489-96
Lund VJ, Stammberger H, Nicolai P, et al. European Rhinologic Society Advisory Board on Endoscopic Techniques in the Management of Nose, Paranasal Sinus and Skull Base Tumours. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl. 2010 Jun 1;22:1-143. PMID: 20502772.
Onkologie:
Grégoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003; 69(3):227-36. doi: 10.1016/j.radonc.2003.09.011.
Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006; 79(1):15-20. doi: 10.1016/j.radonc.2006.03.009.
Grégoire V, Ang K, Budach W, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014; 110(1):172-81. doi: 10.1016/j.radonc.2013.10.010.
Biau J, Lapeyre M, Troussier I, et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019; 134:1-9. doi: 10.1016/j.radonc.2019.01.018.
Brouwer CL, Steenbakkers RJ, Bourhis J, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015; 117(1):83-90. doi: 10.1016/j.radonc.2015.07.041.
Lee AW, Ng WT, Pan JJ, et al. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2018; 126(1):25-36. doi: 10.1016/j.radonc.2017.10.032. Epub 2017 Nov 15.
Grégoire V, Evans M, Le QT, et al. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018; 126(1):3-24. doi: 10.1016/j.radonc.2017.10.016.
Sher DJ, Adelstein DJ, Bajaj GK, et al. Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2017; 7(4): 246-253. doi: 10.1016/j.prro.2017.02.002.
Rehabilitace:
Clarke, P., K. Radford, M. Coffey and M. Stewart. Speech and swallow rehabilitation in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130(S2): S176-S180.
Poléčebné sledování:
Digonnet A, Hamoir M, Andry G, et al. Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013; 270(5):1569-80. doi: 10.1007/s00405-012-2172-7.
Nekhlyudov L, Lacchetti C, Davis NB, et al. Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline. J Clin Oncol. 2017; 35(14):1606-1621. doi: 10.1200/JCO.2016.71.8478.
Simo R, Bradley P, Chevalier D, et al. European Laryngological Society: ELS recommendations for the follow up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol 2014; 271(9): 2469– 2479.